Why Are Wall Street Insiders Moving Their Money to This One Asset?
Something far more consequential for your money than tariffs is unfolding behind the scenes... Tucked inside this overlooked directive is a plan set to be executed for the first time in in U.S. history. One Stansberry Research's Senior Partner says it's set to trigger a rare window for potentially explosive gains in ONE asset immediately. (Not AI or crypto). Wall Street insiders are already positioning themselves... and he insists you should, too, before it's too late.
Shares Stats
| Shares Outstanding | 27,580,000 |
| Shares Float | 26,040,000 |
| Shares Short | 5,930,000 |
| Insider Holdings | 576% |
| Institution Holdings | 114.02% |
About AnaptysBio Inc
AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics. Its products include Rosnilimab, an IgG1 antibody that targets PD-1+ T cells, resulting in their agonism or depletion, broadly impacting pathogenic drivers of autoimmune and inflammatory diseases; and ANB032, a non-depleting antibody that binds to the BTLA checkpoint receptor and inhibits activated T cell proliferation; ANB033, a novel anti-CD122 antagonist antibody that targets the shared common beta subunit of the receptors for IL-15 and IL-2; ANB101, a BDCA2 modulator antibody that specifically targets plasmacytoid dendritic cells (pDCs); and Imsidolimab, an antibody that inhibits the interleukin-36 receptor, which is in the Phase 3 development for the treatment of generalized pustular psoriasis. The company focuses on developing various antibody programs that are advanced to preclinical and clinical milestones under its collaborations. It has a collaboration and license agreement with GlaxoSmithKline, Inc. The company was formerly known as Anaptys Biosciences, Inc. and changed its name to AnaptysBio, Inc. in July 2006. AnaptysBio, Inc. was incorporated in 2005 and is based in San Diego, California.
General
| Name | AnaptysBio Inc |
| Ticker | ANAB |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 136 |
Highlights
| Analyst Target | 63.91 |
| Market Cap | 1,147,000,000 |
| EBITDA | -28,102,000 |
Financials
| Curr Year EPS Estimate | -1.47 |
| Next Quarter EPS Estimate | -0.62 |
| Profit Margin | -49.94% |
| Operating Margin | -16.92 |
| Return on Assets | -0.04 |
| Return on Equity | -3.08 |
| Revenue | 169.5M |
| Earnings Per Share | -2.82 |
| Revenue Per Share | 5.76 |
| Gross Profit | 16,467,000 |
| Quarterly Revenue Growth | 1.54 |
Valuation
| Price/Sales (Trailing 12 Mt.) | 6.87 |
| Price/Book (Most Recent Quarter) | 114.73 |
Earnings
Cathie Wood Dumps $2.4 Million Worth Of Tesla Stock, Doubles Down On These AI Stocks
Cathie Wood-led Ark Invest made significant trades involving Tesla, Pony AI, TSMC, and Baidu, highlighting their strategic positioning in tech & AI sectors.
Space forecasters say severe solar storms could hit Earth and trigger auroras
NEW YORK (AP) — Space weather forecasters issued an alert on Tuesday for incoming severe that could produce and temporarily disrupt communications.
Urgent Copper Stock With Strong Catalysts - Ad
Quebec discovery. Strong grades. Roads and hydro in place. Funding secured for a busy drill calendar. Each assay can build scale and tighten the window for early entries as EVs and data centers pull harder on copper. Do not wait.
Indigenous groups get the spotlight at UN climate talks, but some say visibility isn't power
BELEM, Brazil (AP) — Indigenous people are used to adapting, so when the power failed at their kickoff event at this year's , they rolled with it. Participants from around the world sweated through song, dance and prayers, improvising without microphones and cooling themselves with fans made of paper or leaves.
(Micro)Strategy's Structural Reset: Why Markets Are Repricing MSTR Beyond Bitcoin
The recent decline in Strategy's (NASDAQ:MSTR) stock price is not a simple pullback, nor is it a reaction driven by short-term sentiment. What is unfolding around MSTR is a broad structural repricing.
The Next 'Ozempic Moment' Could Be in Heart Disease - Ad
Just as Ozempic rewrote the obesity playbook, this breakthrough data could transform how we treat inflammatory heart disease. Fully funded. Multiple catalysts. $280B market opportunity.
Chuck Schumer Says 41-Day Shutdown Has Exposed Trump's 'Cruelty,' Accuses President Of Holding Innocent Kids, Veterans As 'Political Hostages'
Schumer condemns Trump's 'cruelty' behind longest shutdown in U.S. history, as thousands of Americans suffer from furloughs and disrupted services.
Asian shares are mostly lower despite Wall St rally and a potential end to the US shutdown
BANGKOK (AP) — Asian shares were mostly lower on Tuesday as the recent rebound fueled by buying of technology shares lost steam.
First Drug to Show Breakthrough Myocarditis Data. Analysts See Potential 7-10x Upside. - Ad
This biotech just delivered a medical first in myocarditis and has a Phase 3 trial fully funded into 2027. Wall Street targets imply massive revaluation ahead.
Officer Injured By January 6 Predicts Trump Will Flee US After 2026 Elections: 'He'll Be Hopping on That Qatari Jet to Saudi Arabia'
Former District of Columbia Metro police officer Michael Fanone has speculated that President Trump might leave the U.S. after the 2026 elections.
Lawsuit challenges TSA's ban on transgender officers conducting pat-downs
A Virginia transportation security officer is accusing the U.S. Department of Homeland Security of sex discrimination over a policy that bars transgender officers from performing security screening pat-downs, according to a federal lawsuit.
Is Big Pharma's Next Target Already in Play? - Ad
A small biotech may have cracked one of medicine's biggest problems-how to deliver cancer drugs safely and effectively. With patented technology and promising early data, it's already catching the attention of Big Pharma.
Shutdown to leave mark on US economy from lost paychecks, canceled flights
WASHINGTON (AP) — The longest federal government shutdown in U.S. history appears to be nearing an end, but not without leaving a mark on an already-struggling economy.
Jim Cramer Notes 'Horrible' Bitcoin Start To December As BTC Falls By $4,000 In Minutes
Bitcoin (CRYPTO: BTC) is down almost 6% in the past 24 hours after a sudden wave of long-position liquidations erased nearly $4,000 from price in a
Bitcoin's Pullback Could Be Your Gain - Ad
More than 70 cryptos have recently outperformed Bitcoin and it's not the first time. During crypto's last bull market the top 100 coins NOT named Bitcoin went up by 174%. Now the signs show that it's happening again. This could be a chance to strike gold in some far corners of the crypto market.
Elon Musk Says Bitcoin Is Based On Energy, The 'True Currency' — Tesla CEO Says His 'Interesting Side Quest' DOGE Is Still Going On
Tesla and SpaceX CEO reiterated in an interview aired Sunday that Bitcoin (CRYPTO: BTC) is based on energy, categorizing it among 
Donald Trump Nullifies 92% Of Joe Biden's Autopen-Signed Documents: 'Cancelling All Executive Orders And Anything Else'
Trump moved to invalidate what he claims are most of Biden's autopen-signed actions, sparking political backlash and renewed debate over the legality and precedent of using mechanical signatures for presidential documents.
Nevada's Mining Renaissance Is Accelerating - And This Early Opportunity Is Well Positioned - Ad
Nevada's Walker Lane belt has produced 50M+ ounces of gold since the 1800s, and it's waking up again. One of the neighborhood's latest successes just secured over $6M in U.S. support and is up more than 300% YTD. Now a new early-stage explorer has moved in next door.
Japan's SoftBank says it has sold its shares in Nvidia for $5.8 billion
TOKYO (AP) — Japanese technology company SoftBank Group Corp. said Tuesday that it has sold all the Nvidia Corp. shares that it owned for $5.83 billion, while it reported higher than expected profit in the first half of this fiscal year.
Swiss voters reject mandatory national service for women and new inheritance tax
GENEVA (AP) — Swiss voters on Sunday decisively rejected a call to require women to do national service in the military, civil protection teams or other forms, as all men must do already.
A Tiny Biotech Just Posted 10× Stronger Cancer Results - Ad
Early studies show this breakthrough delivery platform would make cancer treatments safer and more powerful. Now, with Big Pharma watching closely, investors are starting to take notice of what could be the next major biotech story.
What's Going On With Papa John's (PZZA) Stock Today? (UPDATED)
Shares of Papa John's International, Inc. (NASDAQ: PZZA) moved higher on Monday. Here's what you need to know.
Warren Buffett Won't Buy Gold, And This Valuation Guru Agrees: 'It's A Collectible, Not An Asset'
Why don't Buffett & Damodaran buy gold? The valuation guru explains why gold is a 'collectible,' not an asset you can value.
Copper Is Tight, Silver Is Rising - And This Early Nevada Play Hits the Timing Perfectly - Ad
AI, electrification, battery storage, and data centers are pushing copper and silver demand sharply higher, even as supply stays tight. This region in Nevada offers rare multi-metal potential, and a new company has secured land in a district the surging district. It's one of the cleanest timing setups in the sector right now.
Airbus Orders Emergency Recall Of 6,000 A320 Jets After JetBlue Incident, Triggering Global Flight Delays And Holiday Travel Chaos
Airbus SE (OTC: EADSF) ordered immediate repairs to A320-family aircraft on Friday, recalling 6,000 jets after a recent JetBlue incident.
Apple pulls two gay dating apps in China under government order
BANGKOK (AP) — Apple said it has pulled two of China’s biggest gay dating apps, Blued and Finka, under pressure from Chinese authorities, in the latest sign of a tightening grip on the LGBTQ+ community.
New Number One Copper Start Alert - Ad
EVs and AI devour copper. Supply cannot keep up. A Quebec discovery with high grade, infrastructure, and cheap power is funded to drill through the year. Catalysts are lining up. Institutions are circling. Move now while it is still early.
Joan Branson, wife of British billionaire Richard Branson, dies at 80
Joan Branson, the wife of British billionaire Richard Branson, has died at age 80.
Elon Musk Says SpaceX Will Carry '99% Of All Earth Payload' Once Starship Flies Daily
Elon Musk says SpaceX will handle nearly all of Earth's orbital payloads in the coming years as Starship development continues.
Why Are Wall Street Insiders Moving Their Money to This One Asset? - Ad
Something far more consequential for your money than tariffs is unfolding behind the scenes... Tucked inside this overlooked directive is a plan set to be executed for the first time in in U.S. history. One Stansberry Research's Senior Partner says it's set to trigger a rare window for potentially explosive gains in ONE asset immediately. (Not AI or crypto). Wall Street insiders are already positioning themselves... and he insists you should, too, before it's too late.
Trump-Pardoned Ponzi Schemer Faces 37-Year Sentence For $44 Million COVID Scam
A previously convicted Ponzi schemer who had received a pardon from President Trump is heading back to prison due to involvement in a new fraudulent scheme.
Here's why everyone's talking about a 'K-shaped' economy
WASHINGTON (AP) — From corporate executives to Wall Street analysts to Federal Reserve officials, references to the “K-shaped economy” are rapidly proliferating.
Urgent Copper Stock With Strong Catalysts - Ad
Quebec discovery. Strong grades. Roads and hydro in place. Funding secured for a busy drill calendar. Each assay can build scale and tighten the window for early entries as EVs and data centers pull harder on copper. Do not wait.
Nvidia, Dell, Coinbase, Gorilla Technology And Archer Aviation: Why These 5 Stocks Are On Investors' Radars Today
U.S. stocks closed lower on Monday, with the Dow slipping 1.2% to 46,590.24, the S&P 500 easing 0.92% to 6,672.41, and the Nasdaq dipping 0.84% to 22,708.07. These are the top stocks that gained the attention of retail traders and investors through the day:
The Key to a Winning 401(k)
: when to start, how much to save, and where to invest. The investing decision has drawn more attention as government regulators work to open 401(k) plans to alternative assets such as .
The Next 'Ozempic Moment' Could Be in Heart Disease - Ad
Just as Ozempic rewrote the obesity playbook, this breakthrough data could transform how we treat inflammatory heart disease. Fully funded. Multiple catalysts. $280B market opportunity.
Gen Z Takes To 'Income Stacking' As One Pay Check Falls Short
Gen Zers are turning to income stacking to secure their financial future as they fear a single paycheck won't be enough. AI and broken social contract fuel the shift. Side hustles becoming core of young careers.
Trump Withdraws Support For 'Wacky' Marjorie Taylor Greene In Sudden, Fiery Split: 'I Can't Take...'
President Donald Trump said he is withdrawing his endorsement of longtime ally Rep. Marjorie Taylor Greene — here's what happened.
First Drug to Show Breakthrough Myocarditis Data. Analysts See Potential 7-10x Upside. - Ad
This biotech just delivered a medical first in myocarditis and has a Phase 3 trial fully funded into 2027. Wall Street targets imply massive revaluation ahead.
US Senate Discloses Landmark Crypto Market Structure Bill, Eyes Passage By Late 2025
Bitcoin (CRYPTO: BTC) is holding steady near $105,000 as markets digest the Senate's long-awaited crypto market structure bill draft, a major milestone toward regulatory clarity
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.